On 3 January 2022, a federal jury for the US District Court for the Northern District of California found Holmes guilty in US v. Elizabeth Holmes, on four counts of fraud based on statements made to investors and business partners about Theranos’ proprietary blood testing devices, their capabilities and uses in the market.
Author
Sara Pitt
BrowsingSara Pitt is an associate in Baker McKenzie's Los Angeles office and a member of the Firm's Litigation and Government Enforcement practice. She represents foreign and domestic corporations involved in high-stakes commercial litigation, with a focus on cross-border disputes.